Physician profile
Meghan E Murphy
NPI 1881052710
$1,626.79
in general payments reported to CMS, 2019-2025
15 companies · $239 in 2025
The $239 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $180 · 2022: $572 · 2023: $457 · 2024: $179 · 2025: $239.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $808 · Education: $67.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $807.61 |
| Education | $67.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $373.09 | 2022-2025 | |
| Harmony Biosciences LLC | $325.56 | 2021-2024 | |
| Abbvie INC. | $317.35 | 2023 | |
| Allergan, INC. | $259.46 | 2022 | |
| Avadel Cns Pharmaceuticals, LLC | $63.17 | 2024-2025 | Lumryz |
| Eisai INC. | $43.70 | 2021-2022 | |
| Shield Therapeutics INC | $42.68 | 2025 | |
| Neurelis, INC. | $33.41 | 2022-2023 | Valtoco |
| Inspire Medical Systems, INC. | $30.81 | 2024 | Inspire |
| Sk Life Science, INC. | $29.46 | 2024 | |
| Axsome Therapeutics, INC. | $25.20 | 2022 | |
| Glaxosmithkline, LLC. | $24.61 | 2023 | |
| G1 Therapeutics, INC. | $22.63 | 2021 | |
| Ucb, INC. | $18.15 | 2024 | Rystiggo |
| E.R. Squibb & Sons, L.L.C. | $17.51 | 2025 | Eliquis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Meghan Murphy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.